QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.17 (+0.35%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.17 (+0.35%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.17 (+0.35%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
QQQ   293.34 (+1.95%)
AAPL   143.96 (+1.48%)
MSFT   248.00 (+3.07%)
META   147.30 (+4.10%)
GOOGL   97.52 (+2.42%)
AMZN   99.22 (+2.10%)
TSLA   160.27 (+10.97%)
NVDA   198.02 (+2.48%)
NIO   12.17 (+4.64%)
BABA   120.57 (+0.27%)
AMD   75.17 (+0.35%)
T   20.00 (-2.06%)
MU   62.80 (+2.05%)
F   12.92 (+1.02%)
CGC   2.76 (+0.00%)
GE   81.14 (+0.43%)
DIS   109.70 (+1.46%)
AMC   5.28 (-0.94%)
PFE   44.25 (-1.82%)
PYPL   80.81 (+2.16%)
NFLX   364.87 (-0.84%)
NYSE:AVNS

Avanos Medical - AVNS Stock Forecast, Price & News

$30.15
+0.11 (+0.37%)
(As of 01/26/2023 04:29 PM ET)
Add
Compare
Today's Range
$29.84
$30.42
50-Day Range
$25.97
$30.04
52-Week Range
$19.32
$35.91
Volume
186,802 shs
Average Volume
240,665 shs
Market Capitalization
$1.40 billion
P/E Ratio
33.50
Dividend Yield
N/A
Price Target
$29.33

Avanos Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
2.7% Downside
$29.33 Price Target
Short Interest
Bearish
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.72mentions of Avanos Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
7.89%
From $1.52 to $1.64 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.59 out of 5 stars

Medical Sector

879th out of 1,048 stocks

Surgical Appliances & Supplies Industry

21st out of 23 stocks


AVNS stock logo

About Avanos Medical (NYSE:AVNS) Stock

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Stock News Headlines

AVNS Avanos Medical, Inc.
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
Avanos Medical, Inc. Announces Third Quarter 2022 Results
Avanos Medical (AVNS) Tops Q3 Earnings Estimates
Expert Ratings for Avanos Medical
Avanos Medical Enters Oversold Territory (AVNS)
See More Headlines
Receive AVNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

AVNS Company Calendar

Last Earnings
11/02/2022
Today
1/26/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
4,555
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$29.33
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
-2.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$5.20 million
Pretax Margin
8.15%

Debt

Sales & Book Value

Annual Sales
$744.60 million
Cash Flow
$1.98 per share
Book Value
$26.23 per share

Miscellaneous

Free Float
45,531,000
Market Cap
$1.40 billion
Optionable
Optionable
Beta
0.88

Key Executives

  • Mr. Joseph F. Woody (Age 57)
    CEO & Director
    Comp: $1.68M
  • Mr. Michael C. Greiner (Age 50)
    Sr. VP, CFO & Principal Accounting Officer
    Comp: $711.12k
  • Mr. David Edward Ball (Age 64)
    Sr. VP of Global Supply Chain & Procurement
    Comp: $553.42k
  • Mr. William David Haydon (Age 56)
    Sr. VP & GM of Pain Management
    Comp: $597.29k
  • Mr. Kerr W. Holbrook (Age 56)
    Sr. VP & GM of Chronic Care
    Comp: $611.54k
  • Mr. David Crawford
    VP of FP&A and Investor Relations and Treasurer
  • Ms. Michelle Scharfenberg
    Sr. VP and Chief Ethics & Compliance Officer
  • Ms. Mojirade James (Age 56)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. Scott Galovan
    VP of Strategy & Corp. Devel.
  • Mr. Arjun Ranjan Sarker (Age 57)
    Sr. VP of International













AVNS Stock - Frequently Asked Questions

Should I buy or sell Avanos Medical stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AVNS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View AVNS analyst ratings
or view top-rated stocks.

What is Avanos Medical's stock price forecast for 2023?

2 brokerages have issued 12-month price objectives for Avanos Medical's shares. Their AVNS share price forecasts range from $26.00 to $34.00. On average, they anticipate the company's stock price to reach $29.33 in the next twelve months. This suggests that the stock has a possible downside of 2.4%.
View analysts price targets for AVNS
or view top-rated stocks among Wall Street analysts.

How have AVNS shares performed in 2023?

Avanos Medical's stock was trading at $27.06 at the beginning of 2023. Since then, AVNS stock has increased by 11.0% and is now trading at $30.04.
View the best growth stocks for 2023 here
.

Are investors shorting Avanos Medical?

Avanos Medical saw a increase in short interest during the month of December. As of December 30th, there was short interest totaling 863,600 shares, an increase of 19.2% from the December 15th total of 724,600 shares. Based on an average daily trading volume, of 224,100 shares, the short-interest ratio is currently 3.9 days. Currently, 1.9% of the shares of the company are short sold.
View Avanos Medical's Short Interest
.

When is Avanos Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our AVNS earnings forecast
.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) announced its quarterly earnings data on Wednesday, November, 2nd. The company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. The firm had revenue of $202 million for the quarter, compared to analyst estimates of $205.47 million. Avanos Medical had a trailing twelve-month return on equity of 5.74% and a net margin of 5.39%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.25 earnings per share.

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided EPS guidance of $1.45-$1.65 for the period, compared to the consensus earnings per share estimate of $1.51. The company issued revenue guidance of $815.00 million-$835.00 million, compared to the consensus revenue estimate of $824.62 million.

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.12%), Exchange Traded Concepts LLC (0.08%), Ziegler Capital Management LLC (0.07%), Yousif Capital Management LLC (0.06%), Fulton Bank N.A. (0.02%) and Gateway Investment Advisers LLC (0.02%). Insiders that own company stock include Gary Blackford and Patrick J Oleary.
View institutional ownership trends
.

How do I buy shares of Avanos Medical?

Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $30.04.

How much money does Avanos Medical make?

Avanos Medical (NYSE:AVNS) has a market capitalization of $1.40 billion and generates $744.60 million in revenue each year. The company earns $5.20 million in net income (profit) each year or $0.90 on an earnings per share basis.

How many employees does Avanos Medical have?

The company employs 4,555 workers across the globe.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The official website for the company is avanos.com. The company can be reached via phone at (844) 428-2667 or via email at investor.relations@avanos.com.

This page (NYSE:AVNS) was last updated on 1/26/2023 by MarketBeat.com Staff